Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
07/18/2006 | US7078014 In vivo magnetic resonance imaging by intravenous injection of compounds such as porphyrins, chlorins, bacteriochlorins, and related tetra- pyrrolic compounds with radioactive elements such as Technetium99, Gadolinium, Indium111 and iodine |
07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
07/18/2006 | CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them |
07/13/2006 | WO2006074046A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
07/13/2006 | WO2006073973A2 Novel benzylamine derivatives as cetp inhibitors |
07/13/2006 | WO2006073938A2 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
07/13/2006 | WO2006072470A1 Orthogonally fixed compounds for electrooptical applications |
07/13/2006 | WO2006072336A2 Radioactive metal complexes based on bispidine and derivatives thereof |
07/13/2006 | WO2006041900A3 SUBSTITUTED N-ARYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS |
07/13/2006 | WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors |
07/13/2006 | WO2006038116A3 Triazolopyridine derivatives as antibacterial agents |
07/13/2006 | WO2006019886A3 Pyrrolo(oxo)isoquinolines as 5ht ligands |
07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
07/13/2006 | WO2006004833A3 Pyrrolotriazine kinase inhibitors |
07/13/2006 | WO2005037213A3 Antiinflammatory inhibitors of respiratory burst in adherent neutrophils |
07/13/2006 | WO2004096139A3 Aza spiro alkane derivatives as inhibitors of metalloproteases |
07/13/2006 | US20060155126 Bicyclic heterocycles as cannabinoid receptor modulators |
07/13/2006 | US20060154960 Phosphodiesterase 4 inhibitors |
07/13/2006 | US20060154956 N-(1-Benzyl-2-oxo-1,2,3,4-tetrahydro-1,6-naphthyridin-3-yl)-benzenesulfonamide; CB-1 antagonist; regulating appetitive behavior |
07/13/2006 | US20060154955 Bicyclic heterocycles as cannabinoid receptor modulators |
07/13/2006 | US20060154947 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
07/13/2006 | US20060154930 Substituted amino heterocycles as vr-1 antagonists for treating pain |
07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
07/13/2006 | US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation |
07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
07/13/2006 | US20060154105 Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same |
07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
07/13/2006 | US20060152143 White-emitting compounds, process for the production thereof, and white-emitting devices |
07/13/2006 | CA2605214A1 Benzylamine derivatives as cetp inhibitors |
07/13/2006 | CA2592957A1 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
07/13/2006 | CA2592897A1 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate |
07/13/2006 | CA2589893A1 Inhibitors of checkpoint kinases |
07/13/2006 | CA2588627A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
07/13/2006 | CA2584425A1 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes |
07/12/2006 | EP1679312A2 Cationic symmetric 2-imidazolium diazo compounds with a cationic linking group,compositions comprising them, a dying process and kit thereof |
07/12/2006 | EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
07/12/2006 | EP1678499A2 Chemical compound and assay |
07/12/2006 | EP1678178A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
07/12/2006 | EP1678177A1 Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders |
07/12/2006 | EP1678176A1 Diazabicyclononene derivatives and their use as renin inhibitors |
07/12/2006 | EP1678175A2 Cftr channel modulators |
07/12/2006 | EP1678174A1 Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
07/12/2006 | EP1678173A2 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists |
07/12/2006 | EP1678169A1 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer |
07/12/2006 | EP1678149A2 4-amino(aza)quinoline derivatives as capsaicin receptor agonists |
07/12/2006 | EP1678133A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
07/12/2006 | EP1677799A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain |
07/12/2006 | EP1677791A2 Nitrogen-containing fused heterocyclic compounds |
07/12/2006 | EP1677599A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
07/12/2006 | EP1394156B1 Chromene compound |
07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
07/12/2006 | CN1802377A Tricyclic compound |
07/12/2006 | CN1802376A Cgrp受体拮抗剂 Cgrp receptor antagonists |
07/12/2006 | CN1802375A Beta-carbolines useful for treating inflammatory disease |
07/12/2006 | CN1802374A White-emitting compounds, process for the production thereof, and white-emitting devices |
07/12/2006 | CN1802373A Pyrazoloisoquinoline derivatives as kinase inhibitors |
07/12/2006 | CN1800189A Method for separating vindoline , catharanthine, vinblastine and vincristine from Vinca rosea |
07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
07/12/2006 | CN1800181A Double-functional molecular light switch ruthenium (óÄ) complex and its preparation method |
07/12/2006 | CN1800165A Cationic symmetric 2-imidazolium diazo compounds with a cationic linking group, compositions comprising them, a dying process and kit thereof |
07/12/2006 | CN1799335A Method for improving vinblastine content in madagascar periwinkle |
07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
07/12/2006 | CN1263746C Pyridazinone derivatives |
07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
07/12/2006 | CN1263744C Substituted transannular tetracarboxylic acid diimide |
07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
07/11/2006 | US7074930 Amine salts of an integrin receptor antagonist |
07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
07/11/2006 | US7074928 Polymorphs of clopidogrel hydrogensulfate |
07/11/2006 | US7074927 Heterocyclic amines having central nervous system activity |
07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
07/11/2006 | US7074792 antiserotonine agents; central nervous system disorders; Alzheimer's disease |
07/11/2006 | US7074789 Kinase inhibitors |
07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
07/11/2006 | CA2419314C Preparation of risperidone |
07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
07/11/2006 | CA2227984C Aza-anthracyclinone derivatives |
07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
07/06/2006 | WO2006071862A2 Polymorphs of 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate |
07/06/2006 | WO2006071564A2 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
07/06/2006 | WO2006070408A2 A process for the preparation of substantially pure 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod) |
07/06/2006 | WO2006070385A1 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents |
07/06/2006 | WO2006070379A1 A process for preparation of 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod) |
07/06/2006 | WO2006070198A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
07/06/2006 | WO2006069805A2 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
07/06/2006 | WO2006069788A1 Organic compounds |